In vivo studies in T2DM rats indicate that the butanol fraction decreased blood glucose, increased gut motility, reduced glucose absorption in GIT and improved both plasma and pancreatic insulin levels. The gene discussed is INS; the disease is type 2 diabetes mellitus.